Clinical Trial Update: A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating elritercept alone or with ruxolitinib in adults with myelofibrosis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Elritercept (Elritercept)
• Ruxolitinib (Jakafi) (ruxolitinib)

Snippet

Sponsor: Takeda | Conditions: Myelofibrosis | Phase 2 | Status: RECRUITING